Basic Information
Sucampo is committed to the development and commercialization of specialty pharmaceuticals that meet unmet medical needs for patients worldwide. Sucampo has two marketed products – its lead product AMITIZA and RESCULA – as well as a late-stage pipeline of clinical development candidates in the orphan disease area.
Sucampo Pharmaceuticals, Inc.
Maryland,United States of America
51~100 people
January 01, 1996
--
info@sucampo.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios